Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |